Understanding how Rho protein affects the virulence of C. difficile bacteria
Official title: Rho dependent regulation of Clostridioides difficile virulence
Funded at Univ of North Carolina Chapel Hill · NIH-10825902 · Data updated 2026-11-12
This study is looking at how a specific protein called Rho affects the harmful effects of Clostridioides difficile, a germ that can cause serious gut infections, especially after taking antibiotics, with the goal of finding new ways to treat these infections and help patients feel better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $74,284 |
| NIH project number | 1F32AI181516-01 |
| Project ID | NIH-10825902 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced or are at risk for C. difficile infections, particularly those with a history of antibiotic use.
✕Less likely to help
Patients who do not have C. difficile infections or are not at risk for such infections may not benefit from this research.
What this research studies
This research investigates the role of the Rho protein in regulating the virulence of Clostridioides difficile, a bacterium that can cause severe intestinal infections, particularly after antibiotic use. The study aims to understand how Rho influences the expression of toxins that lead to symptoms like diarrhea and colitis. By exploring the genetic mechanisms involved, the research seeks to identify potential targets for new treatments that could mitigate the harmful effects of this pathogen. Patients may benefit from insights that could lead to more effective therapies for C. difficile infections.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that reduce the severity of C. difficile infections and improve patient outcomes.
How similar studies have gone: Previous research has shown that targeting bacterial regulatory mechanisms can lead to significant advancements in treating infections, suggesting that this approach may also yield promising results.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Plaskon, Dylan — Univ of North Carolina Chapel Hill
- Study coordinator: Plaskon, Dylan
Related research
Other NIH-funded projects on the same topics.
-
A center for coordinating data related to heart and blood health.
This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.
-
Healthy work design and worker well-being
A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
How HPV interacts with our cells' DNA damage system and its effect on cancer
This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.